Heart Disease News and Research

Latest Heart Disease News and Research

Simcere first quarter total revenue increases 5.1% to RMB482.2 million

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today reported unaudited financial results for the first quarter ended March 31, 2011.

10 May 2011

Older heart-transplant recipients more likely to be alive if operated at high-volume centers

Older, sicker heart-transplant recipients are significantly more likely to be alive a year after their operations if they have their transplants at hospitals that do a large number of them annually new Johns Hopkins research suggests. These patients fare less well at low-volume centers, the research shows.

10 May 2011

Geron comments on recent European telomerase peptide cancer vaccine patents

Geron Corporation today commented on a ruling from the European Patent Office with regard to its European patent 084139, and the issuance of a second Geron patent covering telomerase peptides, EP1783139.

10 May 2011

A large belly as dangerous as smoking a pack of cigarettes daily

Did you know that a large belly carries a risk equivalent for coronary artery disease comparable to smoking a pack of cigarettes daily or having high cholesterol? People with coronary artery disease and expanded waistlines are at more than twice the risk of dying, including those with a Body Mass Index (BMI) in the normal range.

10 May 2011

MHA's annual awards recognize outstanding health care leaders, innovative programs

Innovative programs and outstanding leaders in health care were honored Friday, May 6 at the Minnesota Hospital Association's 27th annual awards ceremony at the Metropolitan Ballroom in Minneapolis.

10 May 2011

Gender plays an important role in choosing treatments for clearing clogged arteries

Gender may play an important role when choosing treatment options for clearing dangerously clogged arteries, according to a new study from researchers at the University of Alabama at Birmingham School of Public Health.

10 May 2011

First non-invasive technique to directly map electrical activation of the heart

Abnormalities in cardiac conduction, the rate at which the heart conducts electrical impulses to contract and relax, are a major cause of death and disability around the world. Researchers at Columbia Engineering School have been developing a new method, Electromechanical Wave Imaging, that is the first non-invasive technique to map the electrical activation of the heart.

10 May 2011

CHOP forms first startup firm to develop treatments for peripheral artery disease

Building on its extensive laboratory research using magnetically guided nanoparticles to deliver drugs to diseased blood vessels, The Children's Hospital of Philadelphia has just spun off its first startup company, Vascular Magnetics, Inc.

10 May 2011

Researchers design new tool for identifying protein function from genetic code

Mayo Clinic researchers have designed a new tool for identifying protein function from genetic code. A team led by Stephen Ekker, Ph.D., succeeded in switching individual genes off and on in zebrafish, then observing embryonic and juvenile development.

10 May 2011

Osiris Therapeutics net income increases to $4.0 million for first quarter 2011

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, cardiovascular, wound care and orthopedic areas, announced today its results for the first quarter ended March 31, 2011.

10 May 2011

UCSF scientists receive CIRM grants to advance degenerative muscle disease research

Three UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their investigations of treatment strategies for degenerative muscle diseases, such as muscular dystrophy, and heart disease, and to determine why human embryonic stem cells are susceptible to forming tumors.

10 May 2011

15% strokes occur during sleep making treatment difficult: Study

According to a new study nearly 15 percent of people who have a stroke are not eligible for clot-busting treatment because the stroke happened while they slept. These clot breaking drugs can prevent permanent disability after a stroke - but the treatment must be given within a four-and-a-half-hour window after the stroke symptoms begin say experts. Since people who have a stroke while asleep can't know when it occurred, they can't get the treatment if they slept for more than four and a half hours, explained study author Dr. Jason Mackey at the University of Cincinnati. “They can't get the drug,” he said. “That's a big issue.”

10 May 2011

Painkiller warning for heart patients: Study

According to the latest study, taking some commonly prescribed painkillers for even a short while might increase the risk of dying from a heart attack or stroke. The study also reports that when heart attack survivors took the drugs for as little as a week, it appeared to boost their risk of another heart attack, stroke or sudden death. The results, published in Circulation, a journal of the American Heart Association, surprised even the researchers.

10 May 2011

Research finds 'no safe window' for painkiller use among heart attack survivors

Even short-term use of some painkillers could be dangerous for people who've had a heart attack, according to research published in Circulation: Journal of the American Heart Association.

10 May 2011

Massachusetts patients face long wait times for doctor appointments

A survey conducted by the Massachusetts Medical Society found patients can wait as a long as a month and a half for non-urgent physicians' appointments.

9 May 2011

First Edition: May 9, 2011

"It sounds like a new Apple product, but IPAB is actually a controversial board at the heart of a highly charged battle over Medicare, the federal health program for the elderly and disabled".

9 May 2011

MedCath net revenue increases 0.4% to $97.2 million for second fiscal quarter 2011

MedCath Corporation, a healthcare provider focused on high acuity healthcare services, today announced operating results for its second fiscal quarter ended March 31, 2011. On April 26, 2011, MedCath announced its intention to release the operating results for its second fiscal quarter ended March 31, 2011 on Tuesday, May 10, 2011.

9 May 2011

Lovelace signs definitive agreement to acquire Heart Hospital of New Mexico

Lovelace Health System, Inc. has signed a definitive agreement to purchase the assets and operations of the Heart Hospital of New Mexico from MedCath Corporation for $119 million.

9 May 2011

ArtVentive Medical Group performs animal studies treating target vessels with EOS device

ArtVentive Medical Group, Inc. announced today that the Company performed regulatory animal studies treating target vessels with its occlusion system - device. The procedures had a 100% success rate in terms of safety and effectiveness.

9 May 2011

Preliminary data from ST-DETECT Trial using EGM signals in ICDs presented at SCAI meeting

New data presented today at the Society for Cardiovascular Angiography and Interventions Scientific Sessions are the first to look at the use of highly specialized signals within implantable cardioverter defibrillators to detect restricted blood flow to the heart in high-risk cardiovascular disease patients outside the hospital setting.

9 May 2011

Heart Disease News and Research

Latest Heart Disease News and Research

Simcere first quarter total revenue increases 5.1% to RMB482.2 million

Older heart-transplant recipients more likely to be alive if operated at high-volume centers

Geron comments on recent European telomerase peptide cancer vaccine patents

A large belly as dangerous as smoking a pack of cigarettes daily

MHA's annual awards recognize outstanding health care leaders, innovative programs

Gender plays an important role in choosing treatments for clearing clogged arteries

First non-invasive technique to directly map electrical activation of the heart

CHOP forms first startup firm to develop treatments for peripheral artery disease

Researchers design new tool for identifying protein function from genetic code

Osiris Therapeutics net income increases to $4.0 million for first quarter 2011

UCSF scientists receive CIRM grants to advance degenerative muscle disease research

15% strokes occur during sleep making treatment difficult: Study

Painkiller warning for heart patients: Study

Research finds 'no safe window' for painkiller use among heart attack survivors

Massachusetts patients face long wait times for doctor appointments

First Edition: May 9, 2011

MedCath net revenue increases 0.4% to $97.2 million for second fiscal quarter 2011

Lovelace signs definitive agreement to acquire Heart Hospital of New Mexico

ArtVentive Medical Group performs animal studies treating target vessels with EOS device

Preliminary data from ST-DETECT Trial using EGM signals in ICDs presented at SCAI meeting

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in